Suppr超能文献

利用不同的人群策略评估外周动脉疾病风险。

Estimating the risk of peripheral artery disease using different population strategies.

机构信息

Cardiovascular Epidemiology and Genetics, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

出版信息

Prev Med. 2013 Oct;57(4):328-33. doi: 10.1016/j.ypmed.2013.06.007. Epub 2013 Jun 13.

Abstract

OBJECTIVE

The objective of this study is to compare the clinical performance of different strategies, REASON, PREVALENT, Inter-Society Consensus (ISC), and the American College of Cardiology/American Heart Association (ACC/AHA) Guidelines, in the selection of candidates for peripheral artery disease (PAD) screening using ankle-brachial index (ABI).

METHOD

Our work is a population-based cross-sectional study conducted in Extremadura (Spain) in 2007-2009. Participants were ≥50years old and free of cardiovascular disease. ABI and cardiovascular risk factors were measured.

RESULT

In total, 1288 individuals (53% women), with a mean age of 63years (standard deviation (SD) 9) were included. The prevalence of ABI <0.9 was 4.9%. REASON risk score identified 53% of the sample to screen with sensitivity of 87.3%, quite similar to that identified in ISC and ACC/AHA strategies (both 90.5%), and specificity of 48.3%, higher than that of the ISC (30.9%) and ACC/AHA (31.1%) strategies. Although the Youden index was 0.4 for both REASON and PREVALENT risk scores, the latter's sensitivity was 60.3%, almost 30 points less than all other strategies.

CONCLUSION

REASON risk score was the strategy with the highest clinical performance and efficiency, with sensitivity of 87.3% and specificity higher than that of the ISC and ACC/AHA strategies. Although very specific, the PREVALENT strategy had low sensitivity making it difficult to be implemented as a screening tool.

摘要

目的

本研究旨在比较不同策略(REASON、PREVALENT、ISCA 和 ACC/AHA)在使用踝肱指数(ABI)筛选外周动脉疾病(PAD)患者时的临床性能。

方法

本研究是 2007-2009 年在西班牙埃斯特雷马杜拉进行的一项基于人群的横断面研究。参与者年龄≥50 岁且无心血管疾病。测量了 ABI 和心血管危险因素。

结果

共纳入 1288 名(53%为女性)年龄为 63 岁(标准差 9)的个体。ABI<0.9 的患病率为 4.9%。REASON 风险评分识别出 53%的样本进行筛查,其敏感性为 87.3%,与 ISC 和 ACC/AHA 策略(均为 90.5%)相当,特异性为 48.3%,高于 ISC(30.9%)和 ACC/AHA(31.1%)策略。尽管 REASON 和 PREVALENT 风险评分的约登指数均为 0.4,但后者的敏感性为 60.3%,比所有其他策略低近 30 个百分点。

结论

REASON 风险评分是临床性能和效率最高的策略,其敏感性为 87.3%,特异性高于 ISC 和 ACC/AHA 策略。尽管 PREVALENT 策略非常特异,但敏感性较低,难以作为筛查工具实施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验